பரிமாற்றம் ஒப்புதல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பரிமாற்றம் ஒப்புதல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பரிமாற்றம் ஒப்புதல் Today - Breaking & Trending Today

Falcon Offers Warrant Exercise Incentive Program


Falcon Offers Warrant Exercise Incentive Program
Falcon Gold Corp. ; Announces today that it intends to apply for approval of a warrant exercise incentive program with the TSX Venture Exchange common share and one share purchase warrant for three years at $0.12 from the date of issuance . The Company has 5,750,000 Placement Warrants priced at 12 cents expiring July 13th, 2023.Under the proposed Incentive Program, if the Placement Warrants are exercised prior to …
Falcon Gold Corp. (TSXV:FG)(GR:3FA)(OTC PINK:FGLDF); (“Falcon” or the “Company”) Announces today that it intends to apply for approval of a warrant exercise incentive program (the “Incentive Program”) with the TSX Venture Exchange (the “Exchange ....

Red Lake , United States , British Columbia , Hammond Reef , Karim Rayani , Venture Exchange Approval The Incentive Period , Venture Exchange The , No Directors Or Officers Of The Company , Falcon Gold Corp , Incentive Program , Regulation Services Provider , Venture Exchange , Falcon Gold , Placement Warrants , Vancouver Time , Exchange Approval , Placement Warrant , Each Incentive Warrant , Incentive Warrants , Incentive Period , United States Securities Act , Warrant Incentive Program , Central Canada Gold Mine , Agnico Eagle , Hammond Reef Gold , Camping Lake Gold ,

Hemostemix Inc.: Hemostemix Announces Warrant Repricing and Extension


Hemostemix Inc.: Hemostemix Announces Warrant Repricing and Extension
Calgary, Alberta (Newsfile Corp. - July 5, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) ( Hemostemix or the Company ) is pleased to announce, subject to TSX Venture Exchange Approval, that it has extended for two years and repriced to $0.55 from $1, subject to the accelerator provisions stated below on all repriced warrants, 1,332,500 Warrants expiring July 9, 2021; extended 918,450 Warrants expiring November 24, 2021 of which 510,295 Warrants are repriced to $0.55 (408,155 Warrants held by insiders not repriced from $1); extended 6,360,585 Warrants expiring December 18, 2021, repricing 4,733,559 Warrants (1,627,026 Warrants held by insiders are not repriced from $1); extended 9,166,667 Warrants expiring December 31, 2021, repricing 8,513,334 Warrants (653,333 Warrants held by insiders not repriced from $1). ....

United States , Thomas Smeenk , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Company Counsel , Venture Exchange Approval , Regulation Service Provider , Alberta Newsfile Corp , Venture Exchange , Exchange Approval , Multilateral Instrument , Minority Shareholders , Special Transactions , Ischemic Cardiomyopathy , Dilated Cardiomyopathy , Stem Cell Treatment , Regulating Stem Cells , Vitro Techniques , Stem Cells , Neural Lineage , Automated Cell , Looking Information , Common Shares , ஒன்றுபட்டது மாநிலங்களில் , உலகம் பொருளாதார மன்றம் தொழில்நுட்பம் முன்னோடி விருது , நிறுவனம் ஆலோசனை ,